ERUK and the Association of Medical Research Charities are continuing to monitor events and engage with key stakeholders and the Government on Brexit.

Last month, Epilepsy Research UK joined a coalition of charities led by SUDEP Action to call for the Government to publish the medicines sections of their No-Deal Brexit ‘Yellowhammer’ papers. Acknowledgement has been received from 10 Downing Street in response to the epilepsy coalition’s open letter calling for urgent action to prevent Brexit-related epilepsy deaths.

The updated NHS guidance for getting your medicines in the event of a ‘No-Deal’ Brexit is here.

Urgent action is required to mitigate shortages of medications and disruptions to supply, which could pose a heightened risk for people living with epilepsy. The coalition has flagged this as an urgent concern and called for patient safety to be central to all plans.